Methylmercury directly modifies the 105th cysteine residue in oncostatin M to promote binding to tumor necrosis factor receptor 3 and inhibit cell growth

• Published in: Archives of toxicology 2023-07, Vol.97 (7), p.1887-1897
• Main Authors: Toyama, Takashi, Xu, Sidi, Kanemitsu, Yoshitomi, Hasegawa, Takashi, Noguchi, Takuya, Lee, Jin-Yong, Matsuzawa, Atsushi, Naganuma, Akira, Hwang, Gi-Wook
• Format: Article
• Language: English
• Subjects: Binding; Biomedical and Life Sciences; Biomedicine; Cell growth; Cell membranes; Cell Proliferation; Chemical bonds; Cysteine; Dimethylmercury; Environmental Health; Immunoprecipitation; Mercury (metal); Methionine; Methylmercury; Methylmercury Compounds - toxicity; Molecular Toxicology; Mutants; Occupational Medicine/Industrial Medicine; Oncostatin M; Oncostatin M - chemistry; Oncostatin M - metabolism; Pharmacology/Toxicology; Receptors; Receptors, Tumor Necrosis Factor; Residues; Toxicity; Tumor necrosis factor; Tumor necrosis factor-TNF
• ISSN: 0340-5761; 1432-0738
• DOI: 10.1007/s00204-023-03520-5

We previously found that methylmercury induces expression of oncostatin M (OSM), which is released extracellularly and binds to tumor necrosis factor receptor 3 (TNFR3), possibly enhancing its own toxicity. However, the mechanism by which methylmercury causes OSM to bind to TNFR3 rather than to its known receptors, OSM receptor and LIFR, is unknown. In this study, we aimed to elucidate the effect of methylmercury modification of cysteine residues in OSM on binding to TNFR3. Immunostaining of TNFR3-V5-expressing cells suggested that methylmercury promoted binding of OSM to TNFR3 on the cell membrane. In an in vitro binding assay, OSM directly bound to the extracellular domain of TNFR3, and this binding was promoted by methylmercury. Additionally, the formation of a disulfide bond in the OSM molecule was essential for the binding of both proteins, and LC/MS analysis revealed that methylmercury directly modified the 105th cysteine residue (Cys105) in OSM. Next, mutant OSM, in which Cys105 was replaced by serine or methionine, increased the binding to TNFR3, and a similar effect was observed in immunoprecipitation using cultured cells. Furthermore, cell proliferation was inhibited by treatment with Cys105 mutant OSMs compared with wildtype OSM, and this effect was cancelled by TNFR3 knockdown. In conclusion, we revealed a novel mechanism of methylmercury toxicity, in which methylmercury directly modifies Cys105 in OSM, thereby inhibiting cell proliferation via promoting binding to TNFR3. This indicates a chemical disruption in the interaction between the ligand and the receptor is a part of methylmercury toxicity.